BackBellicum Pharmaceuticals Overview

Bellicum Pharmaceuticals Long Term Debt

Track Bellicum Pharmaceuticals's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Bellicum Pharmaceuticals Long Term Debt History

Loading

Bellicum Pharmaceuticals vs. peers: Long Term Debt Comparison

Loading

Bellicum Pharmaceuticals Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bellicum Pharmaceuticals (BLCM) FAQ

As of the most recent data (September 2023), BLCM shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLCM's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Bellicum Pharmaceuticals is outperforming or lagging.

Tracking BLCM's long-term debt over time shows whether Bellicum Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Bellicum Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

Bellicum Pharmaceuticals's long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.